A common genetic risk C variant in SLC30A8 influences, to different extents, the development of impaired fasting glucose (IFG), the transition from IFG to T2DM [77, 80, 85], and the impairment of glucose metabolism [75, 78]. The gene discussed is SLC30A8; the disease is type 2 diabetes mellitus.